462 related articles for article (PubMed ID: 32722927)
1. Pathogenesis and Treatment Strategies of COVID-19-Related Hypercoagulant and Thrombotic Complications.
Haimei MA
Clin Appl Thromb Hemost; 2020; 26():1076029620944497. PubMed ID: 32722927
[TBL] [Abstract][Full Text] [Related]
2. Viral Coagulopathy in Patients With COVID-19: Treatment and Care.
Kipshidze N; Dangas G; White CJ; Kipshidze N; Siddiqui F; Lattimer CR; Carter CA; Fareed J
Clin Appl Thromb Hemost; 2020; 26():1076029620936776. PubMed ID: 32687449
[TBL] [Abstract][Full Text] [Related]
3. Coagulopathy in COVID-19: Focus on vascular thrombotic events.
Shi W; Lv J; Lin L
J Mol Cell Cardiol; 2020 Sep; 146():32-40. PubMed ID: 32681845
[TBL] [Abstract][Full Text] [Related]
4. COVID-19: Coagulopathy, Risk of Thrombosis, and the Rationale for Anticoagulation.
Miesbach W; Makris M
Clin Appl Thromb Hemost; 2020; 26():1076029620938149. PubMed ID: 32677459
[TBL] [Abstract][Full Text] [Related]
5. Platelet functions and activities as potential hematologic parameters related to Coronavirus Disease 2019 (Covid-19).
Salamanna F; Maglio M; Landini MP; Fini M
Platelets; 2020 Jul; 31(5):627-632. PubMed ID: 32397915
[TBL] [Abstract][Full Text] [Related]
6. Coagulopathy of Coronavirus Disease 2019.
Iba T; Levy JH; Levi M; Connors JM; Thachil J
Crit Care Med; 2020 Sep; 48(9):1358-1364. PubMed ID: 32467443
[TBL] [Abstract][Full Text] [Related]
7. COVID-19 coagulopathy: an evolving story.
The Lancet Haematology
Lancet Haematol; 2020 Jun; 7(6):e425. PubMed ID: 32470428
[No Abstract] [Full Text] [Related]
8. Pharmacotherapy for Prevention and Management of Thrombosis in COVID-19.
Hashemi A; Madhavan MV; Bikdeli B
Semin Thromb Hemost; 2020 Oct; 46(7):789-795. PubMed ID: 32820478
[No Abstract] [Full Text] [Related]
9. COVID-19-Associated Coagulopathy: An Exacerbated Immunothrombosis Response.
Jayarangaiah A; Kariyanna PT; Chen X; Jayarangaiah A; Kumar A
Clin Appl Thromb Hemost; 2020; 26():1076029620943293. PubMed ID: 32735131
[TBL] [Abstract][Full Text] [Related]
10. Emerging evidence of a COVID-19 thrombotic syndrome has treatment implications.
Merrill JT; Erkan D; Winakur J; James JA
Nat Rev Rheumatol; 2020 Oct; 16(10):581-589. PubMed ID: 32733003
[TBL] [Abstract][Full Text] [Related]
11. Prevention and treatment of COVID-19-associated hypercoagulability: Recommendations of the Algerian society of transfusion and hemobiology.
Chekkal M; Deba T; Hadjali S; Lamara H; Oulaa H; Zouai K; Hariti G
Transfus Clin Biol; 2020 Nov; 27(4):203-206. PubMed ID: 33022374
[TBL] [Abstract][Full Text] [Related]
12. Coagulopathy, thromboembolic complications, and the use of heparin in COVID-19 pneumonia.
Costanzo L; Palumbo FP; Ardita G; Antignani PL; Arosio E; Failla G;
J Vasc Surg Venous Lymphat Disord; 2020 Sep; 8(5):711-716. PubMed ID: 32561465
[TBL] [Abstract][Full Text] [Related]
13. A pharmacological perspective of chloroquine in SARS-CoV-2 infection: An old drug for the fight against a new coronavirus?
Oscanoa TJ; Romero-Ortuno R; Carvajal A; Savarino A
Int J Antimicrob Agents; 2020 Sep; 56(3):106078. PubMed ID: 32629115
[TBL] [Abstract][Full Text] [Related]
14. COVID-19 and cardiovascular diseases.
Mai F; Del Pinto R; Ferri C
J Cardiol; 2020 Nov; 76(5):453-458. PubMed ID: 32736906
[TBL] [Abstract][Full Text] [Related]
15. Coagulopathy in COVID-19 and Its Implication for Safe and Efficacious Thromboprophylaxis.
Langer F; Kluge S; Klamroth R; Oldenburg J
Hamostaseologie; 2020 Aug; 40(3):264-269. PubMed ID: 32498097
[TBL] [Abstract][Full Text] [Related]
16. SARS-CoV-2 and coagulation disorders in different organs.
Vinayagam S; Sattu K
Life Sci; 2020 Nov; 260():118431. PubMed ID: 32946915
[TBL] [Abstract][Full Text] [Related]
17. Coagulation changes and thromboembolic risk in COVID-19 obstetric patients.
Benhamou D; Keita H; Ducloy-Bouthors AS;
Anaesth Crit Care Pain Med; 2020 Jun; 39(3):351-353. PubMed ID: 32437961
[No Abstract] [Full Text] [Related]
18. The coagulopathy, endotheliopathy, and vasculitis of COVID-19.
Iba T; Connors JM; Levy JH
Inflamm Res; 2020 Dec; 69(12):1181-1189. PubMed ID: 32918567
[TBL] [Abstract][Full Text] [Related]
19. COVID-19 coagulopathy vs disseminated intravascular coagulation.
Levi M
Blood Adv; 2020 Jun; 4(12):2850. PubMed ID: 32574369
[No Abstract] [Full Text] [Related]
20. A proof of evidence supporting abnormal immunothrombosis in severe COVID-19: naked megakaryocyte nuclei increase in the bone marrow and lungs of critically ill patients.
Roncati L; Ligabue G; Nasillo V; Lusenti B; Gennari W; Fabbiani L; Malagoli C; Gallo G; Giovanella S; Lupi M; Salviato T; Paolini A; Costantini M; Trenti T; Maiorana A
Platelets; 2020 Nov; 31(8):1085-1089. PubMed ID: 32857624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
